Isopropyl Alcohol

Isopropyl Alcohol

SCHEMBL2167428

CC(C)O.O=Cc1ccc(OCCO)cc1

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.54
MAPT P10636 2/20 0.54
HPGD P15428 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
LMNA P02545 1/20 0.54
ALDH1A3 P47895 1/20 0.50
NR1I2 O75469 1/20 0.46
RECQL P46063 1/20 0.46
CYP2A6 P11509 1/20 0.46
GAA P10253 1/20 0.44
CYP3A4 P08684 1/20 0.42
DRD1 P21728 1/20 0.42
TYR P14679 1/20 0.41
S1PR1 P21453 1/20 0.41
S1PR3 Q99500 1/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL145373 0.91 ALDH1A1 (0.58) ALDH1A1MAPTHPGDSMN1; SMN2LMNA
SCHEMBL7213903 0.87 ALDH1A1 (0.54) ALDH1A1MAPTHPGDSMN1; SMN2LMNA
Isopropyl Alcohol SCHEMBL9614865 0.85 ALDH1A1 (0.53) ALDH1A1MAPTHPGDSMN1; SMN2LMNA
SCHEMBL945454 0.82 ALDH1A1 (0.61) ALDH1A1MAPTHPGDSMN1; SMN2LMNA
SCHEMBL28527821 0.81 ALDH1A1 (0.53) ALDH1A1MAPTHPGDSMN1; SMN2LMNA
SCHEMBL2229143 0.81 APP (0.53) ALDH1A1MAPTHPGDSMN1; SMN2LMNA
SCHEMBL3861084 0.81 APP (0.53) ALDH1A1MAPTHPGDSMN1; SMN2LMNA
SCHEMBL4595052 0.81 APP (0.53) ALDH1A1MAPTHPGDSMN1; SMN2LMNA
SCHEMBL4749537 0.81 NR1I2 (0.47) ALDH1A1MAPTHPGDSMN1; SMN2LMNA
SCHEMBL7613986 0.80 ALDH1A1 (0.59) ALDH1A1MAPTHPGDSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117641746-A Transparent conductive substrate and double-sided photolithography method using same 杜邦电子公司 2024-03-01 CN disclosed
US-9823539-B2 Methods and systems for forming optical modulators using micro-contact lithography EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) 2017-11-21 US disclosed
US-20160139484-A1 METHODS AND SYSTEMS FOR FORMING OPTICAL MODULATORS USING MICRO-CONTACT LITHOGRAPHY EMPIRE TECHNOLOGY DEVELOPMENT LLC (DE) 2016-05-19 US disclosed
US-20150268383-A1 SYSTEMS AND METHODS FOR FORMING A LARGE-SCALE MOTHEYE FILM COATING ON A SUBSTRATE TRITON SYSTEMS, INC. (US) 2015-09-24 US disclosed
EP-2520579-B1 A silicone compound, photocurable liquid ink using the silicone compound, and method of manufacturing the ink RICOH CO LTD (JP) 2015-08-05 EP disclosed
WO-2014209294-A1 MICRO-CONTACT LITHOGRAPHY SYSTEMS FORMING OPTICAL MODULATORS EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) 2014-12-31 WO disclosed
US-8871861-B2 Silicone compound, photocurable liquid ink using the silicone compound, and method of manufacturing the ink RICOH COMPANY, LTD. (JP) 2014-10-28 US disclosed
US-8791289-B2 Preparation method of copolymerizable photoinitiators AGFA GRAPHICS NV (BE) 2014-07-29 US disclosed
US-8664431-B2 Preparation method of copolymerizable photoinitiators AGFA GRAPHICS NV (BE) 2014-03-04 US disclosed
US-20140024840-A1 PREPARATION METHOD OF COPOLYMERIZABLE PHOTOINITIATORS AGFA GRAPHICS NV (BE) 2014-01-23 US disclosed
US-7252785-B2 Composition of a radiation-absorbing tert-alkylphenoxy-substituted polycyclic ccmpound and a curable IR-reflecting component of achiral nematic polymerizable monomer, a chiral polymerizable monomer, a cholesteric polymerizable monomer, and a cholesteric polymer in a polymerizable diluent BASF AKTIENGESELLSCHAFT (DE) 2007-08-07 US disclosed
US-20050221091-A1 Composition for producing a thermal insulation coating BASF AKTIENGESELLSCHAFT (DE) 2005-10-06 US disclosed
US-6878399-B2 Method for modifying the surface of biomedical articles NOVARTIS AG (CH) 2005-04-12 US disclosed
EP-1451615-A1 METHOD FOR MODIFYING THE SURFACE OF BIOMEDICAL ARTICLES Novartis AG (CH) 2004-09-01 EP disclosed
US-20030219533-A1 Method for modifying the surface of biomedical articles NOVARTIS AG (CH) 2003-11-27 US disclosed
WO-2003042724-A1 METHOD FOR MODIFYING THE SURFACE OF BIOMEDICAL ARTICLES NOVARTIS AG (CH) 2003-05-22 WO disclosed
EP-0495011-A4 HYDROPHILIC POLYURETHANE ELASTOMERS 1992-08-12 EP disclosed
EP-0495011-A1 HYDROPHILIC POLYURETHANE ELASTOMERS PolyMedica Industries, Inc. (US) 1992-07-22 EP disclosed
US-5118779-A Drug delivery POLYMEDICA INDUSTRIES, INC. (US) 1992-06-02 US disclosed
WO-1991005809-A1 HYDROPHILIC POLYURETHANE ELASTOMERS POLYMEDICA INDUSTRIES, INC. (US) 1991-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140024840-A1 PREPARATION METHOD OF COPOLYMERIZABLE PHOTOINITIATORS HBB, HBZ, HBG1 ALDH1A1 371/4885MAPT 4435/4885HPGD 1344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.